Evidence map›Paper›PMID 37363481›Full record

ArticleAnnals of medicine and surgery (2012)2023

Secondary renal amyloidosis due to primary Sjogren's syndrome: a case report.

Shorsh A Mohammed, Dana O Karim, Saman S Fakhralddin, Rawa Bapir, Tahani Shakr Hadi, Dlsoz M Hussein, Dilan S Hiwa, Hussein M Hamasalih, Sabah J Hasan, Fahmi H Kakamad

Open access · diamondAbstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shorsh A MohammedSmart Health Tower, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq.
Dana O KarimSmart Health Tower, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq.
Saman S FakhralddinSmart Health Tower, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq.
Rawa BapirSmart Health Tower, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq.
Tahani Shakr HadiSmart Health Tower, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq.
Dlsoz M HusseinSmart Health Tower, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq.
Dilan S HiwaCollege of Medicine, University of Sulaimani, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq.
Hussein M HamasalihSmart Health Tower, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq.
Sabah J HasanSmart Health Tower, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq.
Fahmi H KakamadSmart Health Tower, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq.
University of Sulaimani · IQKurdistan Regional Government · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloidosis is a rare disorder characterized by the deposition of abnormal proteins in extracellular tissues, resulting in the dysfunction of vital organs and, eventually, death. The occurrence of amyloidosis due to primary Sjogren's syndrome (pSS) is a rare finding. This study describes a rare case of pSS complicated by amyloid-associated amyloidosis. Case presentation: A 35-year-old male was diagnosed with nephrotic syndrome and secondary amyloidosis caused by pSS. He had microscopic hematuria, a creatinine level of 6.59 mg/dl, and an elevated erythrocyte sedimentation rate of 107 mm/hrs. Furthermore, investigations of antinuclear antibodies, antimitochondrial antibodies, SSA, SSA native, and Ro-52 recombinant as well as rheumatoid factor showed positive results. After establishing the diagnosis of pSS through clinical, physical, and laboratory assessments, a renal biopsy was performed, which revealed the occurrence of secondary amyloidosis. Clinical discussion: The risk of developing secondary amyloidosis depends on the extent of elevated serum amyloid levels as well as persistent subclinical inflammation. The definitive diagnosis of amyloidosis requires histological confirmation of amyloid fibril deposition in tissue. Conclusion: Secondary renal amyloidosis is an unusual condition in patients with pSS. Still, it should be regarded in the differential diagnosis of patients with proteinuria and/or renal failure, and a renal biopsy should be performed.

Indexed as

renal amyloidosisrenal biopsysecondary amyloidosissjogren’s syndrome

Identifiers

PMID37363481
PMCPMC10289626
OpenAlexW4376602668

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.